
Husband & Father. Physician Scientist, MD, PhD, Director of Pancreas Medical Oncology, Director of GI Medical Oncology @ColumbiaMed
New York, USA
Joined May 2022
- Tweets11
- Following66
- Followers187
- Likes3
Gulam Abbas Manji retweeted
Truly an honor to give the
#Keynote Lecture @columbiacancer on Targeting #KRAS in #PancreaticCancer: G12C, RASON, GDP inhibitors, PROTAC, vaccines and much more!!!
🙏🙏 @DrGManji and faculty for the kind invite and congratulations on a fantastic symposium!!!
Happy to report that our trial in gastric cancer published in JAMAOnc. Privileged to have worked with @mdmanishshah, @ParkHaesong, and AlexRaufi. Thanks to all the patients who participated in the study.
Proud to report the results of the pilot phase of our investigator-initiated clinical trial @AACR Pancreas.
I started the preclinical study in KPC mice in @KenOliveLab and then work continued in my lab. Randomized phase 2 to activate soon at 5 sites!
Gulam Abbas Manji retweeted
On the latest episode of Columbia Conversations & Curbsides, Dr. Gulam Manji (@DrGManji) sits down to share updates on the current state of pancreatic cancer care. @ColumbiaSurgery
Listen here: open.spotify.com/episode/7ma…
Gulam Abbas Manji retweeted
Oncologist and director of medical oncology and translational #PanCan research, @DrGManji joined @hyesooLoweMD to discuss the past, present, and future of pancreatic cancer—from genetic mutations to clinical-trial awareness and personalized treatment: columbiasurgery.org/news/new…
Thank you for the discussion, @hyesooLoweMD. It brings much needed attention to pancreatic cancer and highlights the need for more patients to enroll in clinical trials. #PanCan
Oncologist and director of medical oncology and translational #PanCan research, @DrGManji joined @hyesooLoweMD to discuss the past, present, and future of pancreatic cancer—from genetic mutations to clinical-trial awareness and personalized treatment: columbiasurgery.org/news/new…
1
6
Gulam Abbas Manji retweeted
Comprehensive discussion by @LizzySmyth1 of the phase II trial by Dr. Gulam Manji et al➡️ peri-operative chemotherapy/pembrolizumab in resectable gastric/OGJ adenoca followed by adjuvant pembro. Proof of principle of increased RR; phase 3 data awaited @AACR #AACR22.
Thanks @KenOliveLab for the warm welcome to Twitter! Finally joining in to highlight the great work being done in GI immuno-oncology
Everybody welcome to Twitter former OliveLab trainee @DrGManji, now leading our pancreas med/onc program @columbiacancer @PancreasCenter and leading a research program in pancreatic cancer immuno-oncology. Amazing clinical trialist and cancer researcher! #scitwitter
3













